Mok Tony
莫树锦
Medical Oncologist, Lung Cancer Center
Areas of Expertise
30+
Years of Experience
Professional Biography
Dr. Mok Tony is Medical Oncologist, Lung Cancer Center at Shenzhen United Family Hospital, Shenzhen. Mok serves as Chairman, Department of Clinical Oncology, Chinese University of Hong Kong. Clinical expertise includes Non-small cell lung cancer (NSCLC), EGFR-mutated lung cancer, ALK-positive lung cancer, Immunotherapy for lung cancer. Designed and led the IPASS trial (NEJM 2009) — the global landmark study establishing first-line gefitinib for EGFR-mutation-positive advanced lung cancer, defining the era of precision medicine in thoracic oncology. Fellowship in Medical Oncology, Princess Margaret Hospital, Toronto, Canada. ESMO Lifetime Achievement Award (2018) — first Chinese recipient; Giants of Cancer Care® 2020 (OncLive).
Medipath provides comprehensive support for international patients. Services include full English-speaking medical consultations, dedicated medical translation staff, and specialized assistance with medical visa applications to ensure a seamless healthcare journey.
English Consultations
Full English-speaking medical appointments
Medical Translation
Dedicated translation for all documentation
Visa Assistance
Medical visa application support